Tomiyama T - Search Results

1

Clinical course of patients with familial early-onset Alzheimer's disease potentially lacking senile plaques bearing the E693Δ mutation in amyloid precursor protein.

Shimada H, Ataka S, Tomiyama T, Takechi H, Mori H, Miki T. Shimada H, et al. Among authors: tomiyama t. Dement Geriatr Cogn Disord. 2011;32(1):45-54. doi: 10.1159/000330017. Epub 2011 Aug 13. Dement Geriatr Cogn Disord. 2011. PMID: 21846988

2

Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro.

Tomiyama T, Asano S, Suwa Y, Morita T, Kataoka K, Mori H, Endo N. Tomiyama T, et al. Biochem Biophys Res Commun. 1994 Oct 14;204(1):76-83. doi: 10.1006/bbrc.1994.2428. Biochem Biophys Res Commun. 1994. PMID: 7945395

3

Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid beta protein analogues.

Tomiyama T, Asano S, Furiya Y, Shirasawa T, Endo N, Mori H. Tomiyama T, et al. J Biol Chem. 1994 Apr 8;269(14):10205-8. J Biol Chem. 1994. PMID: 8144598 Free article.

4

Missense point mutations of tau to segregate with FTDP-17 exhibit site-specific effects on microtubule structure in COS cells: a novel action of R406W mutation.

Sahara N, Tomiyama T, Mori H. Sahara N, et al. Among authors: tomiyama t. J Neurosci Res. 2000 May 1;60(3):380-7. doi: 10.1002/(SICI)1097-4547(20000501)60:3<380::AID-JNR13>3.0.CO;2-5. J Neurosci Res. 2000. PMID: 10797541

5

Molecular pathogenesis of apolipoprotein E-mediated amyloidosis in late-onset Alzheimer's disease.

Tomiyama T, Corder EH, Mori H. Tomiyama T, et al. Cell Mol Life Sci. 1999 Oct 15;56(3-4):268-79. doi: 10.1007/s000180050428. Cell Mol Life Sci. 1999. PMID: 11212354 Free PMC article. Review.

6

Distinguishable effects of presenilin-1 and APP717 mutations on amyloid plaque deposition.

Ishii K, Lippa C, Tomiyama T, Miyatake F, Ozawa K, Tamaoka A, Hasegawa T, Fraser PE, Shoji S, Nee LE, Pollen DA, St George-Hyslop PH, Ii K, Ohtake T, Kalaria RN, Rossor MN, Lantos PL, Cairns NJ, Farrer LA, Mori H. Ishii K, et al. Among authors: tomiyama t. Neurobiol Aging. 2001 May-Jun;22(3):367-76. doi: 10.1016/s0197-4580(01)00216-0. Neurobiol Aging. 2001. PMID: 11378241

7

Enhanced Abeta40 deposition was associated with increased Abeta42-43 in cerebral vasculature with Dutch-type hereditary cerebral hemorrhage with amyloidosis (HCHWA-D).

Ozawa K, Tomiyama T, Maat-Schieman ML, Roos RA, Mori H. Ozawa K, et al. Among authors: tomiyama t. Ann N Y Acad Sci. 2002 Nov;977:149-54. doi: 10.1111/j.1749-6632.2002.tb04810.x. Ann N Y Acad Sci. 2002. PMID: 12480745

8

Lack of amyloid plaque formation in the central nervous system of a patient with Werner syndrome.

Mori H, Tomiyama T, Maeda N, Ozawa K, Wakasa K. Mori H, et al. Among authors: tomiyama t. Neuropathology. 2003 Mar;23(1):51-6. doi: 10.1046/j.1440-1789.2003.00474.x. Neuropathology. 2003. PMID: 12722926

9

Mutation (D472Y) in the type 3 repeat domain of cartilage oligomeric matrix protein affects its early vesicle trafficking in endoplasmic reticulum and induces apoptosis.

Hashimoto Y, Tomiyama T, Yamano Y, Mori H. Hashimoto Y, et al. Among authors: tomiyama t. Am J Pathol. 2003 Jul;163(1):101-10. doi: 10.1016/S0002-9440(10)63634-6. Am J Pathol. 2003. PMID: 12819015 Free PMC article.

10

Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form.

Kanemitsu H, Tomiyama T, Mori H. Kanemitsu H, et al. Among authors: tomiyama t. Neurosci Lett. 2003 Oct 23;350(2):113-6. doi: 10.1016/s0304-3940(03)00898-x. Neurosci Lett. 2003. PMID: 12972166

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

384 results

Search Page

Filters